Formation of the androgen receptor transcription complex

被引:548
作者
Shang, YF
Myers, M
Brown, M
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1016/S1097-2765(02)00471-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgen receptor (AR) is required for sexual differentiation and is implicated in the development of prostate cancer. Here we describe distinct functions for cofactor proteins and gene regulatory elements in the assembly of AR-mediated transcription complexes. The formation of an activation complex involves AR, coactivators, and RNA polymerase H recruitment to both the enhancer and promoter, whereas the formation of a repression complex involves factors bound only at the promoter and not the enhancer. These results suggest a model for the functional coordination between the promoter and enhancer in which communication between these elements is established through shared coactivators in the AR transcription complex.
引用
收藏
页码:601 / 610
页数:10
相关论文
共 64 条
[31]   RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2 [J].
Li, H ;
Gomes, PJ ;
Chen, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8479-8484
[32]   p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin [J].
Li, JW ;
O'Malley, BW ;
Wong, JM .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (06) :2031-2042
[33]   Structural evidence for ligand specificity in the binding domain of the human androgen receptor -: Implications for pathogenic gene mutations [J].
Matias, PM ;
Donner, P ;
Coelho, R ;
Thomaz, M ;
Peixoto, C ;
Macedo, S ;
Otto, N ;
Joschko, S ;
Scholz, P ;
Wegg, A ;
Bäsler, S ;
Schäfer, M ;
Egner, U ;
Carrondo, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26164-26171
[34]   Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation [J].
McInerney, EM ;
Rose, DW ;
Flynn, SE ;
Westin, S ;
Mullen, TM ;
Krones, A ;
Inostroza, J ;
Torchia, J ;
Nolte, RT ;
Assa-Munt, N ;
Milburn, MV ;
Glass, CK ;
Rosenfeld, MG .
GENES & DEVELOPMENT, 1998, 12 (21) :3357-3368
[35]   Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase [J].
Nagy, L ;
Kao, HY ;
Chakravarti, D ;
Lin, RJ ;
Hassig, CA ;
Ayer, DE ;
Schreiber, SL ;
Evans, RM .
CELL, 1997, 89 (03) :373-380
[36]  
Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121
[37]   The transcriptional coactivators p300 and CBP are histone acetyltransferases [J].
Ogryzko, VV ;
Schiltz, RL ;
Russanova, V ;
Howard, BH ;
Nakatani, Y .
CELL, 1996, 87 (05) :953-959
[38]  
ONATE SA, 1995, SCIENCE, V270, P1354
[39]   PROSTATE TISSUE-SPECIFICITY OF THE PROSTATE-SPECIFIC ANTIGEN PROMOTER ISOLATED FROM A PATIENT WITH PROSTATE-CANCER [J].
PANG, S ;
TANEJA, S ;
DARDASHITI, K ;
COHAN, P ;
KABOO, R ;
SOKOLOFF, M ;
TSO, CL ;
DEKERNION, JB ;
BELLDEGRUN, AS .
HUMAN GENE THERAPY, 1995, 6 (11) :1417-1426
[40]  
Pang S, 1997, CANCER RES, V57, P495